Hospital admissions due to infections in the national population of people with multiple sclerosis on disease-modifying therapies: Real-world data from NHS England

被引：0
|
作者：
Garjani, Afagh [1 ,2 ]
Osborne, Nick [3 ]
Law, Graham [4 ]
Nightingale, Matthew [3 ]
Evangelou, Nikos [1 ,2 ]
机构：
[1] Univ Nottingham, Sch Med, Mental Hlth & Clin Neurosci Acad Unit, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, Neurol Clin, Nottingham, England
[3] NHS Arden & Greater East Midlands Commissioning S, Leicester, Leics, England
[4] Univ Lincoln, Sch Hlth & Social Care, Coll Hlth & Sci, Lincoln, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O091/2549
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [21] Real-world effectiveness of initial treatment with newer versus injectable disease-modifying therapies in pediatric multiple sclerosis in the US
    Krysko, K. M.
    Graves, J. S.
    Rensel, M.
    Weinstock-Guttman, B.
    Rutatangwa, A.
    Aaen, G.
    Benson, L.
    Chitnis, T.
    Gorman, M.
    Goyal, M.
    Harris, Y.
    Krupp, L.
    Lotze, T.
    Mar, S.
    Moodley, M.
    Rodriguez, M.
    Rose, J.
    Schreiner, T.
    Waltz, M.
    Casper, T. C.
    Waubant, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 97 - 98
  • [22] Characteristics of a population exposed to a disease-modifying drug for multiple sclerosis in the real-world setting (1996-2017)
    Ng, H. S.
    Zhu, F.
    Kingwell, E.
    Zhao, Y.
    Evans, C.
    Svenson, L.
    Fisk, J.
    Marrie, R. A.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 330 - 331
  • [23] Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria - A real world study
    Seitaridou, Yoana
    Chamova, Teodora
    Kamusheva, Maria
    PHARMACIA, 2024, 71 : 1 - 7
  • [24] Real-world titration of disease modifying therapies in the treatment of multiple sclerosis: findings from a survey of neurologists
    Nazareth, T.
    Marvel, J.
    Sikirica, S.
    Xie, J.
    Reichmann, W.
    Zhao, C.
    Sasane, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 204 - 204
  • [25] Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US
    Abrams, A.
    Waltz, M.
    Casper, T. C.
    Aaen, G.
    Benson, L.
    Charvet, L.
    Chitnis, T.
    Francisco, C.
    Gorman, M.
    Goyal, M.
    Graves, J.
    Krupp, L.
    Lotze, T.
    Mar, S.
    Rensel, M.
    Rodriguez, M.
    Rose, J.
    Rutatangwa, A.
    Schreiner, T.
    Shukla, N.
    Weinstock-Guttman, B.
    Wheeler, Y.
    Waubant, E.
    Krysko, K.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 56 - 58
  • [26] Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US
    Abrams, Aaron
    Waltz, Michael
    Casper, Theron
    Aaen, Gregory
    Benson, Leslie
    Charvet, Leigh
    Chitnis, Tanuja
    Francisco, Carla
    Gorman, Mark
    Goyal, Manu
    Graves, Jennifer
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Rensel, Mary
    Rodriguez, Moses
    Rose, John
    Rutatangwa, Alice
    Schreiner, Teri
    Shukla, Nikita
    Tillema, Jan-Mendelt
    Weinstock-Guttman, Bianca
    Wheeler, Yolanda
    Waubant, Emmanuelle
    Krysko, Kristen
    NEUROLOGY, 2023, 100 (17)
  • [27] Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine
    Etemadifar, Masoud
    Abhari, Amir Parsa
    Nouri, Hosein
    Eighani, Naghme
    Salari, Mehri
    Sedaghat, Nahad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 444
  • [28] Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy
    Fyfe I.
    Nature Reviews Neurology, 2016, 12 (7) : 372 - 372
  • [29] Real-World Treatment Persistence Among Multiple Sclerosis Patients on Injectable Disease Modifying Therapies
    Ko, John
    Nicholas, Jacqueline
    Navaratnam, Prakash
    Friedman, Howard
    Ernst, Frank
    Herrera, Vivian
    NEUROLOGY, 2017, 88
  • [30] Underutilization of Disease-Modifying Therapies in Sickle Cell Disease: A Real-World Analysis from the ASH Research Collaborative Data Hub
    Niss, Omar
    Fenchel, Matthew
    Kingsley, Erin
    Latham, Teresa S.
    Malik, Punam
    Quinn, Charles T.
    BLOOD, 2024, 144 : 2312 - 2313
12345